Talk:Chronic eosinophilic leukemia

Medicine: Hematology-oncology Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force (assessed as Low-importance).

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Chronic eosinophilic leukemia.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Imatinib[edit]

Imatinib is used in PDGFRA-FIL1P1 fusion, but it turns out that a very low weekly dose is sufficient: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2141.2008.07033.x JFW | T@lk 11:06, 25 March 2008 (UTC)[reply]